NCT03441581View on ClinicalTrials.gov

Eluxadoline Bile Acid Malabsorption (BAM) Study

PHASE4CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

April 28, 2020

Study Completion Date

April 28, 2020

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG

Eluxadoline

Eluxadoline 100 mg oral tablets BID with food.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY